The global spinal fusion device market was valued at USD 11.62 billion in 2025 and is projected to grow from USD 12.33 billion in 2026 to USD 20.26 billion by 2035, registering a CAGR of 5.7% during the forecast period, according to the latest report published by Global Market Insights Inc.
Spinal fusion devices play an essential role in treating degenerative disc disease, spinal deformities, fractures, instability, and other conditions affecting the vertebral column. These products include fixation systems, interbody cages, bone graft substitutes, biologics, and supporting surgical instruments used across cervical and thoracolumbar procedures.
The rising burden of spinal disorders, expansion of minimally invasive surgery, and increasing adoption of advanced implants are collectively supporting market growth. Manufacturers are also moving beyond conventional hardware towards integrated procedural platforms that combine implants, biologics, navigation technologies, and workflow solutions.
Key growth drivers
- The growing prevalence of low back pain and degenerative spinal conditions is expanding the number of patients requiring specialist treatment. Population ageing is further increasing the incidence of disc degeneration, spinal stenosis, instability, and other conditions that may require surgical intervention.
- The migration of spinal fusion procedures to ambulatory surgical centres is accelerating market expansion. Minimally invasive techniques, shorter recovery periods,